Updated

US Health Secretary Robert F. Kennedy Jr. has moved to expand access to peptides that have not been approved by regulators, according to BBC US & Canada reporting on October 29, 2026. The BBC reported the change without giving further detail on its legal mechanism or timing. Health experts have cautioned against use of the drugs, citing a lack of clinical trials in humans and unknown long-term effects. The expansion is likely to draw continued scrutiny from medical professionals over safety and oversight.